MedAssets Introduces First Module of Revenue Cycle

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MedAssets Introduces First Module of Revenue Cycle Analytics Product Suite

ATLANTA, June 24, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq: MDAS ) today announced the introduction of Contract Analytics, the first module of Revenue Cycle Analytics , a robust analytical discovery product suite designed to improve revenue cycle efficiency and visibility into reimbursement performance. MedAssets is showcasing Contract Analytics, along with its full portfolio of revenue cycle management solutions at the 2014 HFMA National Institute, June 22-25 in Las Vegas (Booth #412).

Contract Analytics provides dynamic access to critical revenue cycle data to enable executives and front-line associates alike to gain timely insights into reimbursement trends, recognize issues and variances in payor performance, and identify impacts to operational goals. As a result, health system leaders are empowered to take swift action with fact-based decisions. Tool features include:

  • Data aggregation from multiple sources including data from MedAssets Contract Management product and the health system's patient accounting system(s)
  • Interactive key performance indicator dashboards. Each dashboard provides analytical discovery through summary views and drill down capabilities to line item level
  • Standard and ad hoc reporting capabilities that leverage hundreds of revenue cycle data elements to enable root cause analysis in minutes
  • Accessibility via iPad application enabling on-the-go performance monitoring and decisions

"Many providers struggle with the massive amount of healthcare information plus scarce time, technology and project management resources to unlock data into usable business intelligence," said Amy Amick, president, Revenue Cycle Management, MedAssets. "Contract Analytics combines MedAssets extensive payor and reimbursement expertise with our innate understanding of the inner working of a hospital's operational and financial data. It's the first of in a series of business intelligence tools we're introducing  to support financial leaders, analysts and front-line employees to improve operational efficiency, optimize reimbursements and minimize risk."

Unlocking valuable revenue cycle data to optimize reimbursement and performance

Sentara Healthcare, a not-for-profit health system based in Virginia, is among the first health systems to adopt the MedAssets Contract Analytics tool.

"Eight of our 12 hospitals are live on the new revenue cycle product from MedAssets and at this early stage its capabilities are very impressive," said Andrew P. Weddle, vice president, Revenue Cycle, for Sentara Healthcare. "We are excited to leverage this powerful analytical tool to help us better identify ways to optimize reimbursement."

A comprehensive portfolio of analytics and insight

As hospitals contend with increased regulation and public scrutiny, there is increased need for data transparency to support fact-based decisions across multiple constituents across provider organizations. The introduction of Contract Analytics builds upon the wide array of proprietary data and analytics tools MedAssets offers to multiple hospital departments and constituents to improve quality of care, efficiency and financial performance. Whether the focus is Cost Analytics for clinical utilization standardization, such as supply and pharmacy spend expense, Revenue Cycle Analytics  for sustained margin improvement, Operational Analytics for clinical resource management and strategic planning, or Clinical Analytics to identify risk and savings opportunities related to bundled payments, MedAssets offers business intelligence solutions to help drive decisions that reduce the total cost of care, enhance operational efficiency, align clinical delivery and improve revenue performance.

About Sentara Healthcare

Sentara Healthcare celebrates a 125-year history of innovation, compassion and community benefit. Based in Norfolk, VA, Sentara is a diverse not-for-profit family of 12 hospitals, an array of integrated services and a team 27,000 strong on a mission to improve health every day. This mandate is pursued through a disciplined strategy to achieve Top 10% performance in key measures through shared best practices, transformation of primary care through clinical integration and strategic growth that adds value to the communities we serve in Virginia and North Carolina. For more information, please visit www.sentara.com .

About MedAssets

MedAssets (Nasdaq: MDAS ) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care , enhance operational efficiency , align clinical delivery , and improve revenue performance across the care continuum. For more information, please visit www.medassets.com .

MDAS/B

Media Contact: Robin Wrinn 678.624.7420 Investor Contact: Robert Borchert 678.248.8194

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 144

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 242

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Franklin Universal Trust Distributions Explained: A Deep Dive

Updated Category News Views 225

Understanding Franklin Universal Trust's Distribution Sources In the investment landscape, knowing the sources of distributions can significantly inform investors about the health of their investments. Franklin Universal Trust (NYSE: FT) recently provided an update on its distribution sources, which is vital for shareholders seeking to gauge the Fund’s performance....

Continue Reading
Bitcoin Flat, Ethereum Up: Is This Your Accumulation Moment?

Updated Category News Views 149

Bitcoin's been stuck in neutral territory lately, trading flat as of Monday with a mild dip in volatility due to holiday-driven thin liquidity. It pushed up to $70,060 but faced serious resistance, retreating back into the $68,000 zone where it seems to be camping out. Volume? Yeah, that dropped a cool 17% from yesterday's action—so you know how traders get restless...

Continue Reading
Automotive Wiper Blade Market Set for Robust Expansion

Updated Category News Views 121

Anticipated Growth in the Automotive Wiper Blade Market The global automotive wiper blade market is poised for significant growth in the coming years. Projections estimate that the market value will climb to USD 11.5 billion by 2034, up from USD 6 billion in 2024. This increase signifies a compound annual growth rate (CAGR) of 6.8%. Key drivers of this growth include...

Continue Reading
Celebrated Financial Advisor Joins Ameriprise, Enhancing Services

Updated Category News Views 190

Gary Presslaff Joins Ameriprise Financial Team In a significant move for the financial services landscape, mentor Gary Presslaff has officially joined the ranks of Ameriprise Financial, Inc. (NYSE: AMP). With four decades of industry experience, Presslaff brings a wealth of knowledge and expertise, bolstering the team at Monumental Financial Planning located in Washington...

Continue Reading
Royal Mint Celebrates Iconic Metal Band with Special Coin

Updated Category News Views 237

Royal Mint Commemorative Coin for Iron Maiden's 50th Anniversary The Royal Mint has recently unveiled an impressive commemorative coin that celebrates the remarkable 50-year journey of the legendary heavy metal band, Iron Maiden. This special release is part of The Royal Mint's Music Legends series, which has previously honored iconic musicians such as Queen, Elton John,...

Continue Reading